Detalhe da pesquisa
1.
Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 22(6): 1356-63, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527750
2.
Phase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer.
Cancer J
; 9(4): 286-92, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12967139
3.
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale Experience.
J Clin Oncol
; 4(5): 817, 1986 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423288
4.
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer.
Oncologist
; 7(5): 410-7, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12401903